Cascade Investment Advisors, Inc. Abb Vie Inc. Transaction History

Cascade Investment Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$144.61 - $166.54 $58,711 - $67,615	406 New	406 $64,000
Q1 2022 Apr 11, 2022	BUY	$131.98 - $163.75 $32,995 - $40,937	250 Added 160.26%	406 $65,000
Q2 2020 Jul 15, 2020	BUY	$73.37 - $98.18 $4,108 - $5,498	56 Added 56.0%	156 $15.3 Million
Q2 2018 Jul 31, 2018	SELL	$89.78 - $106.23 $29,627 - $35,055	-330 Reduced 76.74%	100 $9.27 Million
Q3 2017 Oct 12, 2017	BUY	$69.85 - $89.22 $30,035 - $38,364	430	430 $38.2 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Cascade Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Cascade Investment Advisors, Inc. with notifications on news.